Cited by 692Advanced Glycation End Products researchImmune Response and InflammationSystemic Lupus Erythematosus Research

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

Harris, Helena Erlandsson, Andersson, Ulf, Pisetsky, David S.·2012·Nature Reviews Rheumatology

DOI 10.1038/nrrheum.2011.222

Open this paper in CoChat — free account

Abstract

HMGB1 is a non-histone nuclear protein that can serve as an alarmin to drive the pathogenesis of inflammatory and autoimmune disease. Although primarily located in the cell nucleus, HMGB1 can translocate to the cytoplasm, as well as the extracellular space, during cell activation and cell death; during activation, HMGB1 can undergo post-translational modifications. The activity of HMGB1 varies with the redox states of the cysteine residues, which are required for binding to TLR4. In addition to stimulating cells directly, HMGB1 can form immunostimulatory complexes with cytokines and other endogenous and exogenous factors. In the synovia of patients with rheumatoid arthritis, as well as animal models of this disease, extranuclear expression of HMGB1 is increased and blockade of HMGB1 expression attenuates disease in animal models. In systemic lupus erythematosus, HMGB1 can be a component of immune complexes containing anti-DNA because of its interaction with DNA. In myositis, expression of HMGB1 is enhanced in inflamed muscle and can perturb muscle function. Together, these findings indicate that HMGB1 might be an important mediator and biomarker in rheumatic diseases as well as a target of new therapy.

Integrity signals

Registry

Crossref · 10.1038/nrrheum.2011.222

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 retracted

Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1)
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407
Self-citation
Retracted
Diet Restriction Inhibits Apoptosis and HMGB1 Oxidation and Promotes Inflammatory Cell Recruitment during Acetaminophen Hepatotoxicity
Antoine, D. J., Williams, D. P., Kipar, A., Laverty, H., & Park, B. K. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00126 · Cited by 102
Retracted
Increased serum high mobility group box-1 level in Churg–Strauss syndrome THIS ARTICLE HAS BEEN RETRACTED
Taira, T., Matsuyama, W., Mitsuyama, H., Kawahara, K.-I., Higashimoto, I., Maruyama, I., Osame, M., & Arimura, K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03347.x · Cited by 20
Retracted
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Self-citation
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein
Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,582
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437
Self-citation
High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes
Andersson, U., Wang, H., Palmblad, K., Aveberger, A.-C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.565 · Cited by 1,401
Self-citation
Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372

Flagged first, then by citations

Show all 93 references

Sorted by citations

Items 201–300 of 692

A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome
Slambrouck, J. V., Raemdonck, D. E. V., Vos, R., Vanluyten, C., Vanstapel, A., Prisciandaro, E., Willems, L., Orlitová, M., Kaes, J., Jin, X., et al. (2022) · Cells · doi:10.3390/cells11040745 · Cited by 50
The role of platelets in the pathogenesis of systemic sclerosis
Ramirez, G. A., Franchini, S., Rovere, P. Q., Sabbadini, M. G., Manfredi, A. A., & Maugeri, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00160 · Cited by 46
Non-lethal heat shock induces HSP70 and HMGB1 protein production sequentially to protect Artemia franciscana against Vibrio campbellii
Norouzitallab, P., Baruah, K., Muthappa, D. M., & Bossier, P. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.11.017 · Cited by 46
The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity
Li, L., & Lu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601815 · Cited by 46
Inflammation and Immune System Activation After Traumatic Brain Injury
Balu, R. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0484-2 · Cited by 47
RETRACTED ARTICLE: HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms
Yang, X., Wang, H., Zhang, M., Liu, J., Lv, B., & Chen, F. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0348-3 · Cited by 45
Retracted
HMGB1 + microparticles present in urine are hallmarks of nephritis in patients with systemic lupus erythematosus
Burbano, C., Gómez-Puerta, J. A., Muñoz‐Vahos, C. H., Vanegas-García, A. L., Rojas, M., Vásquez, G. M., & Castaño, D. (2018) · European Journal of Immunology · doi:10.1002/eji.201847747 · Cited by 45
Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features
Garcia, L. P. W., Torres-Ruiz, J. J., Zentella‐Dehesa, A., Rodríguez, M. T., Alcocer-Varela, J. C., Huerta, N. V. M., & Gómez‐Martín, D. (2019) · Lupus · doi:10.1177/0961203319883936 · Cited by 46
MicroRNA-548 regulates high mobility group box 1 expression in patients with preterm birth and chorioamnionitis
Son, G., Kim, Y., Lee, J. J., Lee, K.-Y., Ham, H., Song, J., Park, S. T., & Kim, Y. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-56327-9 · Cited by 46
Resistin family proteins in pulmonary diseases
Lin, Q., & Johns, R. A. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00040.2020 · Cited by 44
Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases
García‐Martinez, I., Shaker, M. E., & Mehal, W. Z. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6383 · Cited by 44
Identification and Characterization of the Direct Interaction between Methotrexate (MTX) and High-Mobility Group Box 1 (HMGB1) Protein
Kuroiwa, Y., Takakusagi, Y., Kusayanagi, T., Kuramochi, K., Imai, T., Hirayama, T., Ito, I., Yoshida, M., Sakaguchi, K., & Sugawara, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063073 · Cited by 43
Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis
Nicolosi, P. A., Tombetti, E., Maugeri, N., Rovere, P. Q., Brunelli, S., & Manfredi, A. A. (2016) · Stem Cells International · doi:10.1155/2016/4636859 · Cited by 45
Increased Neutrophil Activation and Plasma DNA Levels in Patients with Pre-Eclampsia
Hu, Y., Li, H., Yan, R., Wang, C., Wang, Y., Zhang, C., Liu, M., Zhou, T., Zhu, W., Zhang, H., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1675788 · Cited by 43
Age‐dependent release of high‐mobility group box protein‐1 and cellular neuroinflammation after traumatic brain injury in mice
Webster, K. M., Sun, M., Crack, P. J., O'Brien, T. J., Shultz, S. R., & Semple, B. D. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24589 · Cited by 44
Polyhexamethyleneguanidine phosphate induces cytotoxicity through disruption of membrane integrity
Song, J., Jung, K. J., Yoon, S., Lee, K., & Kim, B. (2019) · Toxicology · doi:10.1016/j.tox.2019.01.001 · Cited by 43
Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats
Qian, J., Zhu, Y., Bai, L., Gao, Y., Jiang, M., Xing, F., Zhang, J., Zhao, W., Gu, H., Mi, Y., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00800-w · Cited by 43
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation
Vitali, R., Palone, F., Pierdomenico, M., Negroni, A., Cucchiara, S., Aloi, M., Oliva, S., & Stronati, L. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.039 · Cited by 42
Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells
Chandrasekaran, K. S., Sathyanarayanan, A., & Karunagaran, D. (2016) · Tumor Biology · doi:10.1007/s13277-016-5261-1 · Cited by 43
Middle‐ear dexamethasone delivery via ultrasound microbubbles attenuates noise‐induced hearing loss
Shih, C., Chen, H., Lin, Y., Chen, H., Wang, H., Kuo, C., Lin, Y.-Y., & Wang, C. (2018) · The Laryngoscope · doi:10.1002/lary.27713 · Cited by 42
New markers in ulcerative colitis
Nakov, R. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.033 · Cited by 42
One SNP in the 3′-UTR of HMGB1 gene affects the binding of target bta-miR-223 and is involved in mastitis in dairy cattle
Li, L., Huang, J., Zhang, X., Ju, Z., Qi, C., Zhang, Y., Li, Q., Wang, C., Miao, W., Zhong, J., et al. (2012) · Immunogenetics · doi:10.1007/s00251-012-0641-1 · Cited by 42
Activation of Toll-like Receptor-2 by Endogenous Matrix Metalloproteinase-2 Modulates Dendritic-Cell-Mediated Inflammatory Responses
Godefroy, E., Gallois, A., Idoyaga, J., Mérad, M., Tung, N., Monu, N. R., Saenger, Y. M., Fu, Y., Ravindran, R., Pulendran, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.067 · Cited by 41
Effect of Lipopolysaccharide Administration on the Number, Phenotype and Content of Nuclear Molecules in Blood Microparticles of Normal Human Subjects
Soop, A., Hållström, L., FROSTELL, C. G., Wallén, H., Mobarrez, F., & Pisetsky, D. S. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12076 · Cited by 41
Self-citation
Regulation of autophagy by systemic admission of microRNA-141 to target HMGB1 in l-arginine-induced acute pancreatitis in vivo
Zhu, H., Huang, L., Zhu, S., Li, X., Li, Z., Yu, C., & Yu, X. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.004 · Cited by 41
Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells
Hashemi-Niasari, F., Rabbani‐Chadegani, A., Razmi, M., & Fallah, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.019 · Cited by 42
Association of plasma level of high-mobility group box-1 with necroptosis and sepsis outcomes
Yoo, H., Im, Y., Ko, R., Lee, J. Y., Park, J., & Jeon, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-88970-6 · Cited by 41
Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction
Wang, S., Dong, J., Li, L., Wu, R., Xu, L., Ren, Y., & Hu, X. (2021) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3268 · Cited by 41
Ginsenoside Rh2 Inhibits NLRP3 Inflammasome Activation and Improves Exosomes to Alleviate Hypoxia-Induced Myocardial Injury
Qi, Z., Yan, Z., Wang, Y., Ji, N., Yang, X., Zhang, A., Li, M., Xu, F., & Zhang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883946 · Cited by 41
Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease
Thakur, V., Nargis, S., Gonzalez, M., Pradhan, S., Terreros, D. A., & Chattopadhyay, M. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000477820 · Cited by 41
Platelet extracellular vesicles in COVID-19: Potential markers and makers
Puhm, F., Flamand, L., & Boilard, É. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0221-100r · Cited by 40
HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation
Jeong, J., Lee, D. H., & Song, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112933 · Cited by 40
Does Infection-Induced Immune Activation Contribute to Dementia?
Tatiana, Jaqueline, Jessica, Allan, Pitcher, M. R., Simões, L. R., Quevedo, J., & Dal‐Pizzol, F. (2015) · Aging and Disease · doi:10.14336/ad.2015.0521 · Cited by 40
Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
Pan, L., Wang, F., Wu, J., Wang, C., Yan, J., Li, Z.-L., Song, J., & Wang, J. (2017) · Disease Markers · doi:10.1155/2017/7293459 · Cited by 39
Alarmin HMGB1 Plays a Detrimental Role in Hippocampal Dysfunction Caused by Hypoxia-Ischemia Insult in Neonatal Mice: Evidence from the Application of the HMGB1 Inhibitor Glycyrrhizin
Le, K., Wu, S., Chibaatar, E., Ali, A. I., & Guo, Y. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00084 · Cited by 39
LincRNA‐EPS alleviates severe acute pancreatitis by suppressing HMGB1‐triggered inflammation in pancreatic macrophages
Chen, S., Zhu, J., Sun, L., Liu, S., Zhang, T., Jin, Y., Huang, C., Li, D., Yao, H., Huang, J. A., et al. (2021) · Immunology · doi:10.1111/imm.13313 · Cited by 39
Helicobacter pylori Activates HMGB1 Expression and Recruits RAGE into Lipid Rafts to Promote Inflammation in Gastric Epithelial Cells
Lin, H., Hsu, F.-Y., Chen, W.-W., Lee, C.-H., Lin, Y.-J., Chen, Y. M., Chen, C., Huang, M.-Z., Kao, M.-C., Chen, Y.-A., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00341 · Cited by 39
Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson’s disease like pathology in Zebrafish
Ren, Q., Jiang, X. J., Paudel, Y. N., Gao, X., Gao, D., Zhang, P., Sheng, W., Shang, X., Liu, K., Zhang, X., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115234 · Cited by 38
The role of ferroptosis in fish inflammation
Gao, F., Shi, X., Pei, C., Zhao, X., Zhu, L., Zhang, J., Li, L., Li, C., & Kong, X. (2022) · Reviews in Aquaculture · doi:10.1111/raq.12719 · Cited by 38
Induction of acute lung inflammation in mice with hemorrhagic shock and resuscitation: role of HMGB1
Kao, R. L. C., Xu, X., Xenocostas, A., Parry, N. G., Mele, T. S., Martin, C. M., & Rui, T. (2014) · Journal of Inflammation · doi:10.1186/s12950-014-0030-7 · Cited by 38
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
Wang, Y., Jiang, Z., Yan, J., & Ying, S. (2019) · Disease Markers · doi:10.1155/2019/4183157 · Cited by 35
Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis
Gao, F., & Zhang, S.-Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1591427 · Cited by 37
Using PAMPs and DAMPs as adjuvants in cancer vaccines
Sun, H., Hu, W., Yan, Y., Zhang, Z., Chen, Y., Yao, X., Teng, L., Wang, X., Chai, D., Zheng, J., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1964316 · Cited by 40
HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization
Chen, Q., Bei, J.-J., Liu, C., Feng, S.-B., Zhao, W.-B., Zhou, Z., Yu, Z.-P., Du, X.-J., & Hu, H.-Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156686 · Cited by 38
Association of circulating blood HMGB1 levels with ischemic stroke: a systematic review and meta-analysis
Le, K., Mo, S., Lu, X., Abdoulaye, I. A., Yu, D., & Guo, Y. (2018) · Neurological Research · doi:10.1080/01616412.2018.1497254 · Cited by 37
Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis
Vicentino, A. R. R., Carneiro, V. C., Allonso, D., Guilherme, R. F., Benjamim, C. F., dos Santos, H. A. M., Xavier, F. R., Pyrrho, A. D. S., Gomes, J. D. A. S., Fonseca, M. D. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01979 · Cited by 37
Homeostatic and pathogenic roles of the GM3 ganglioside
Inokuchi, J., Kanoh, H., Inamori, K., Nagafuku, M., Nitta, T., & Fukase, K. (2021) · FEBS Journal · doi:10.1111/febs.16076 · Cited by 38
The Role of HMGB1 in Rheumatic Diseases
Dong, Y., Ming, B., & Dong, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.815257 · Cited by 40
Alarmin Function of Galectin-9 in Murine Respiratory Tularemia
Steichen, A. L., Simonson, T. J., Salmon, S. L., Metzger, D. W., Mishra, B. B., & Sharma, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123573 · Cited by 36
Is serum HMGB1 a biomarker in ANCA-associated vasculitis?
de Souza, A. W. S., Westra, J., Bijzet, J., Limburg, P. C., Stegeman, C. A., Bijl, M., & Kallenberg, C. G. M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4284 · Cited by 36
The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease
Richards, R. I., Robertson, S. A., O’Keefe, L. V., Fornarino, D. L., Scott, A., Lardelli, M. T., & Baune, B. T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00193 · Cited by 39
Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis
Park, M.-J., Lee, S. H., Moon, S., Lee, J.-A., Lee, E., Kim, E., Park, J., Lee, J. J., Min, J., Kim, S. J., et al. (2016) · Scientific Reports · doi:10.1038/srep35933 · Cited by 36
Angiotensin II enhances the acetylation and release of HMGB1 in RAW264.7 macrophage
Zhou, S., Lu, H., Chen, R., Tian, Y., Jiang, Y., Zhang, S., Ni, D., Su, Z., & Shao, X. (2018) · Cell Biology International · doi:10.1002/cbin.10984 · Cited by 35
Reactive oxygen species induce Cys106-mediated anti-parallel HMGB1 dimerization that protects against DNA damage
Kwak, M. S., Rhee, W. J., Lee, Y. J., Kim, H. S., Kim, Y. H., Kwon, M. K., & Shin, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101858 · Cited by 37
Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade
Lindblom, J., Mohan, C., & Parodis, I. (2022) · Brain Science · doi:10.3390/brainsci12020192 · Cited by 35
HMGB1, angel or devil, in ischemic stroke
Gao, B., Wang, S., Li, J., Han, N., Ge, H., Zhang, G., & Chang, M. (2023) · Brain and Behavior · doi:10.1002/brb3.2987 · Cited by 32
Identification of Pharmacological Modulators of HMGB1-Induced Inflammatory Response by Cell-Based Screening
Gerő, D., Szoleczky, P., Módis, K., Pribis, J. P., Al‐Abed, Y., Yang, H., Chevan, S., Billiar, T. R., Tracey, K. J., & Szabó, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065994 · Cited by 35
Systemic High-Mobility Group Box-1: A Novel Predictive Biomarker for Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage*
Chaudhry, S. R., Güresir, Á., Stoffel‐Wagner, B., Fimmers, R., Kinfe, T. M., Dietrich, D., Lamprecht, A., Vatter, H., Güresir, E., & Muhammad, S. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003319 · Cited by 35
HMGB1/autophagy pathway mediates the atrophic effect of TGF-β1 in denervated skeletal muscle
Yang, X., Xue, P., Liu, X., Xu, X., & Chen, Z. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0310-6 · Cited by 35
Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome
Manganelli, V., Truglia, S., Capozzi, A., Alessandri, C., Riitano, G., Spinelli, F. R., Ceccarelli, F., Mancuso, S., Garofalo, T., Longo, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00460 · Cited by 36
Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension
Goldenberg, N. M., Hu, Y., Hu, X., Volchuk, A., Zhao, Y. D., Kucherenko, M. M., Knosalla, C., de Perrot, M. E., Tracey, K. J., Al‐Abed, Y., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201808-1597le · Cited by 35
Prunella vulgaris L. Attenuates Experimental Autoimmune Thyroiditis by Inhibiting HMGB1/TLR9 Signaling
Guo, Q., Qu, H., Zhang, H., & Zhong, X. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s325814 · Cited by 35
HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production
Chen, X., Li, L., Khan, M. N., Shi, L., Wang, Z., Zheng, F., Gong, F., & Fang, M. (2016) · Innate Immunity · doi:10.1177/1753425916669862 · Cited by 35
Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis
Brambilla, L., Martorana, F., Guidotti, G., & Rossi, D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00622 · Cited by 34
Late Peaks of HMGB1 and Sepsis Outcome: Evidence For Synergy With Chronic Inflammatory Disorders
Karakike, E., Adami, M., Lada, M., Gkavogianni, T., Koutelidakis, I. M., Bauer, M. W., Giamarellos‐Bourboulis, E. J., & Tsangaris, I. (2018) · Shock · doi:10.1097/shk.0000000000001265 · Cited by 34
High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potential
Paudel, Y. N., Angelopoulou, E., Bhuvan, K. C., Piperi, C., & Othman, I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116924 · Cited by 35
Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis
Sfera, A., Osorio, C. P., del Campo, C. M. Z.-M., Pereida, S., Maurer, S., Maldonado, J. C., & Kozlakidis, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673217 · Cited by 34
Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma
Shi, W., Su, L., Li, Q., Sun, L., Lv, J., Li, J., & Cheng, B. (2014) · Tumor Biology · doi:10.1007/s13277-014-2268-3 · Cited by 35
The function of hematopoietic stem cells is altered by both genetic and inflammatory factors in lupus mice
Niu, H., Fang, G., Tang, Y., Xie, L., Yang, H., Morel, L. M., Diamond, B., & Zou, Y.-R. (2013) · Blood · doi:10.1182/blood-2012-05-433755 · Cited by 35
Aurozyme: A Revolutionary Nanozyme in Colitis, Switching Peroxidase‐Like to Catalase‐Like Activity
Kim, H. S., Lee, S., & Lee, D. Y. (2023) · Small · doi:10.1002/smll.202302331 · Cited by 34
Inflammation-related signaling pathways in tendinopathy
Jiang, L., Liu, T., Lyu, K., Chen, Y., Lu, J., Wang, X., Long, L., & Li, S. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0729 · Cited by 37
Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy
Koide, H., Kiyokawa, C., Okishima, A., Saito, K., Yoshimatsu, K., Fukuta, T., Hoshino, Y., Asai, T., Nishimura, Y., Miura, Y., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c06799 · Cited by 33
Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer
Hu, Q., Wang, R., Zhang, J., Xue, Q., & Ding, B. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03564-7 · Cited by 34
Emerging role of high mobility group box 1 in ANCA-associated vasculitis
Wang, C., de Souza, A. W. S., Westra, J., Bijl, M., Chen, M., Zhao, M., & Kallenberg, C. G. M. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.010 · Cited by 32
NELL-1, HMGB1, and CCN2 Enhance Migration and Vasculogenesis, But Not Osteogenic Differentiation Compared to BMP2
Fahmy‐Garcia, S., van Driel, M., Witte‐Bouma, J., Walles, H., van Leeuwen, J. P. T. M., van Osch, G. J. V. M., & Farrell, E. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0537 · Cited by 33
Activation of the HMGB1-TLR4-NF-κB pathway may occur in patients with atopic eczema
Wang, Y., Weng, H., Song, J., Deng, Y. H., Li, S., & Liu, H. B. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6942 · Cited by 33
KPT-330, a potent and selective CRM1 inhibitor, exhibits anti-inflammation effects and protection against sepsis
Wu, M. T., Gui, H., Feng, Z., Xu, H., Li, G., Li, M., Chen, T., Wu, Y., Huang, J., Bai, Z., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.112 · Cited by 33
Programmed Cell Death in the Small Intestine: Implications for the Pathogenesis of Celiac Disease
Perez, F., Ruera, C. N., Miculán, E., Carasi, P., & Chirdo, F. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147426 · Cited by 33
TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies
Heinz, R., & Schneider, U. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012618 · Cited by 33
High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE)
Abdulahad, D. A., Westra, J., Reefman, E., Zuidersma, E., Bijzet, J., Limburg, P. C., Kallenberg, C., & Bijl, M. (2013) · Lupus · doi:10.1177/0961203313483377 · Cited by 32
Modulating mighty microglia
Block, M. L. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1691 · Cited by 34
HMGB1 in severe soft tissue infections caused by Streptococcus pyogenes
Johansson, L., Snäll, J., Sendi, P., Linnér, A., Thulin, P., Linder, A., Treutiger, C.-J., & Norrby‐Teglund, A. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00004 · Cited by 32
O-GlcNAcylation of High Mobility Group Box 1 (HMGB1) Alters Its DNA Binding and DNA Damage Processing Activities
Balana, A. T., Mukherjee, A., Nagpal, H., Moon, S. P., Fierz, B., Vásquez, K. M., & Pratt, M. R. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c06192 · Cited by 32
Damage associated molecular patterns in necrotic femoral head inhibit osteogenesis and promote fibrogenesis of mesenchymal stem cells
Deng, Z., Ren, Y., Park, M. S., & Kim, H. K. W. (2021) · Bone · doi:10.1016/j.bone.2021.116215 · Cited by 33
The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation
Bawadekar, M., Andrea, M. D., Cigno, I. L., Baldanzi, G., Caneparo, V., Graziani, A., Landolfo, S., & Gariglio, M. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0168 · Cited by 34
Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease
Alisi, A., Nobili, V., Ceccarelli, S., Panera, N., Stefanis, C. D., Vito, R. D., Vitali, R., Bedogni, G., Balsano, C., Cucchiara, S., et al. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.928205 · Cited by 35
Redox distress and genetic defects conspire in systemic autoinflammatory diseases
Varga, G., Gattorno, M., Foell, D., & Rubartelli, A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.105 · Cited by 31
HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells
Tang, L., Chai, W., Ye, F., Yu, Y. P., Cao, L., Yang, M., Xie, M., & Yang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.15432 · Cited by 31
Glycyrrhizin, a Potential Drug for Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1
Li, J., Shi, J., Sun, Y., & Zheng, F. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4444 · Cited by 31
Regulation of HMGB1 release protects chemoradiotherapy-associated mucositis
Im, K.-I., Nam, Y.-S., Kim, N., Song, Y., Lee, E., Lim, J.-Y., Jeon, Y., & Cho, S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0132-x · Cited by 33
New insights into the protection of growth hormone in cisplatin-induced nephrotoxicity: The impact of IGF-1 on the Keap1-Nrf2/HO-1 signaling
Mahran, Y. F. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117581 · Cited by 31
HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis
Muth, I. E., Zschüntzsch, J., Kleinschnitz, K., Wrede, A., Gerhardt, E., Balcarek, P., Schreiber‐Katz, O., Zierz, S., Dalakas, M. C., Voll, R. E., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.023 · Cited by 31
Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum
Ramirez, G. A., Maugeri, N., Sabbadini, M. G., Rovere, P. Q., & Manfredi, A. A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12223 · Cited by 31
Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets
Haq, S. A., & Tournadre, A. (2015) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12736 · Cited by 30
Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders
Huang, Q., Shen, S., Qu, H., Huang, Y., Wu, D., Jiang, H., & Yuan, C. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.44 · Cited by 30
The role of nuclear factors as “Find-Me”/alarmin signals and immunostimulation in defective efferocytosis and related disorders
Tajbakhsh, A., Rezaee, M., Barreto, G. E., Moallem, S. A., Henney, N. C., & Sahebkar, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106134 · Cited by 30
NETosis in Rheumatic Diseases
Jariwala, M., & Laxer, R. M. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-020-00977-6 · Cited by 32
Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
Zhou, X., Zhang, Y., & Wang, N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915784 · Cited by 30
Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation
Lu, T., Xu, X.-L., Du, X., Wei, J., Yu, J., Deng, S., & Qin, C. (2022) · Cells · doi:10.3390/cells11233865 · Cited by 32
Proteolytic inactivation of nuclear alarmin high-mobility group box 1 by complement protease C1s during apoptosis
Yeo, J. G., Leong, J. Y., Arkachaisri, T., Cai, Y., Teo, B. H. D., Tan, J. H., Das, L., & Lu, J. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.69 · Cited by 29

Authors: Harris, H. E., Andersson, U., & Pisetsky, D. S.
Affiliations: Karolinska Institutet (SE)
Karolinska University Hospital (SE)
Durham VA Medical Center (US)
Corresponding author: Pisetsky, David S.
ORCID: Harris, Helena Erlandsson
Pisetsky, David S.
Venue: Nature Reviews Rheumatology
Publisher: Springer Science and Business Media LLC
Published: 2012-01-31
Volume: 8
Issue: 4
Pages: 195-202
ISSN: 1759-4790 (ISSN-L)
1759-4804
DOI: 10.1038/nrrheum.2011.222
OpenAlex: W1972204333
Cited by: 689
References: 93
Citations by year: 2026: 20 · 2025: 31 · 2024: 32 · 2023: 34 · 2022: 54 · 2021: 61 · 2020: 50 · 2019: 59 · 2018: 65 · 2017: 57 · 2016: 53 · 2015: 52 · 2014: 55 · 2013: 49 · 2012: 16
FWCI: 6.55
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Rheumatology (publishedVersion)
PubMed (publishedVersion)
Funders: Vetenskapsrådet
Reumatikerförbundet
National Institutes of Health
National Institute of Allergy and Infectious Diseases (AI-056363, U19AI056363)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords: HMGB1, alarmins, non-histone nuclear proteins, rheumatoid arthritis, systemic lupus erythematosus, myositis, inflammation, autoimmune disease, TLR4, post-translational modification, cysteine redox state, extracellular HMGB1, immune complexes, anti-DNA antibodies, synovium, biomarkers, therapeutic target
MeSH terms: Animals, Autoimmune Diseases, DNA-Binding Proteins, Humans, Inflammation, Rheumatic Diseases, Signal Transduction, HMGB1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks